Humanin
HN, Mitochondrial-derived peptide
Overview
Humanin is a 24-amino acid mitochondrial-derived peptide that plays a critical role in cellular protection and metabolic regulation. It is recognized for its potent cytoprotective properties, particularly against apoptotic stimuli in various tissues.
Research Summary
Humanin was first identified in 2001 and has since become a major focus in gerontology and mitochondrial research. Research indicates that it acts as a signaling molecule that modulates intracellular stress pathways. Studies in rodent models have demonstrated that Humanin can mitigate damage caused by Alzheimer's-related amyloid-beta peptides and improve glucose metabolism. Furthermore, it has shown efficacy in protecting vascular endothelium and improving insulin sensitivity. Its ability to cross the blood-brain barrier and enhance longevity in model organisms makes it a highly significant candidate for future therapeutic applications in metabolic and neurodegenerative diseases.
Mechanism of Action
Humanin functions by interacting with the tripartite receptor complex composed of CNTF receptor alpha, WSX-1, and gp130. This interaction triggers the activation of the STAT3 signaling pathway, which is essential for cell survival and anti-apoptotic defense.
Additionally, Humanin inhibits the activity of BAX, a pro-apoptotic protein, preventing it from permeabilizing the mitochondrial membrane. By maintaining mitochondrial integrity and modulating the unfolded protein response, Humanin effectively counters cellular stress and prevents programmed cell death.
Common Discussion Topics
This compound is for research use only and is not intended for human consumption or clinical use.
Discussion
Commenting as guest — your email won't be shown publicly.
Stay Updated
Get the latest peptide research insights delivered to your inbox.